Hyaluxelle®

Medical device

Hyaluxelle® is indicated for adult women to treat the vulvar vestibule in case of vaginal atrophy, dryness, burning or itching (not infectious), vaginal introitus pain during intercourse5.

Click here to find the IFU

Hyaluxelle pre-filled syringe box by IBSA - Injectable hyaluronic acid solution (3.2%) with NAHYCO Hybrid Technology

Highlights

Protocol

Two treatment sessions with an interval of 30 days, following the suggested injection technique5

Improvement

Improvement in vaginal symptoms and sexual function in patients with VVA2,3,4

Tolerability

Well tolerated in the genital area2

Quality of life

Positive trend on HRQoL4

Technology

NAHYCO®Hybrid technology: stabilised high and low molecular weights Hyaluronic acid (HA) for a synergistic contribution to tissue regeneration from in vitro trial1.

Clinical evidence

Clinical studies show:

Clinical studies show improvement in vaginal symptoms of VVA2

Can support the restoration of vaginal tissue structure3

Improvement in sexual function2,4

Well tolerated safety profile2,3

Can benefit impact on frequency of sexual intercourse, emotions and can improve relationships2,4

Contact IBSA

Additional resources

Ballerina performing a jump next to a large origami swan structure, symbolizing physical lightness and freedom of movement

Patient Information Leaflet

Download
Ballerina performing a jump next to a large origami swan structure, symbolizing physical lightness and freedom of movement

Injection Technique

Back to the Hyaluxelle® product line

If your patient gets any side-effects, please report them. This includes any possible side effects not listed in the package leaflet. You can also report side-effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk.

To report a side effect or product complaint to IBSA Pharma please contact IBSA Pharma Ltd on 01923 233466 and medicalinformation.uk@ibsagroup.com.

Artistic metaphor of a woman emerging from a marble statue, symbolizing tissue regeneration and the restoration of vitality

Section reserved for healthcare professionals

This section contains information intended for healthcare professionals. By continuing, you confirm that you are a healthcare professional authorized to access this content.

Are you a healthcare professional (HCP)?

No, go back

References

  • 1 / Humzah D, et al. Int J Mol Sci. 2024;25(6):3216.
  • 2 / Garavaglia E, et al. Med Devices (Auckl). 2020;13:399-410.
  • 3 / Garavaglia E, et al. Aesthetic Medicine. 2023;9(1):35-42.
  • 4 / Mohammed GF, et al. Health Sci Rep. 2023;6(3):e870.
  • 5 / HYALUXELLE®. Instructions for Use.